197 related articles for article (PubMed ID: 2081487)
41. Flunoxaprofen, a new non-steroidal anti-inflammatory drug, does not interfere with prostaglandin synthesis in rat gastric mucosa.
Sacchi C; Magni F; Toia A; Cazzaniga F; Galli G; Berti F
Pharmacol Res; 1989; 21(2):177-82. PubMed ID: 2748505
[TBL] [Abstract][Full Text] [Related]
42. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
43. Etodolac: effect on prostaglandin concentrations in gastric mucosa of rats.
Lee D; Dvornik D
Life Sci; 1985 Mar; 36(12):1157-62. PubMed ID: 3157036
[TBL] [Abstract][Full Text] [Related]
44. Indomethacin and paracetamol: interaction with prostaglandin synthesis in the rat stomach.
Van Kolfschoten AA; Hagelen F; Van Noordwijk J
Eur J Pharmacol; 1982 Oct; 84(1-2):123-5. PubMed ID: 6754389
[TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal damage demonstrated with nabumetone or etodolac in preclinical studies.
Spangler RS
Am J Med; 1993 Aug; 95(2A):35S-39S. PubMed ID: 8357001
[TBL] [Abstract][Full Text] [Related]
46. Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.
Bannwarth B
Drug Saf; 2008; 31(6):485-503. PubMed ID: 18484783
[TBL] [Abstract][Full Text] [Related]
47. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
[TBL] [Abstract][Full Text] [Related]
48. Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
Dallob A; Hawkey CJ; Greenberg H; Wight N; De Schepper P; Waldman S; Wong P; DeTora L; Gertz B; Agrawal N; Wagner J; Gottesdiener K
J Clin Pharmacol; 2003 Jun; 43(6):573-85. PubMed ID: 12817520
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of prostacyclin and thromboxane A2 by rat gastric mucosa. Comparison of 1,6-dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido (1,1-a)-pyrimidine-3-carboxamide and cimetidine.
Rózsa I; Kapui Z; Szécsi T; Hermecz I; Blaskó G
Arzneimittelforschung; 1989 Jun; 39(6):686-9. PubMed ID: 2673252
[TBL] [Abstract][Full Text] [Related]
50. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.
Coersmeier C; Wittenberg HR; Aehringhaus U; Dreyling KW; Peskar BM; Brune K; Peskar BA
Agents Actions Suppl; 1986; 19():137-54. PubMed ID: 3092600
[TBL] [Abstract][Full Text] [Related]
51. Clinical pharmacokinetics of nabumetone. The dawn of selective cyclo-oxygenase-2 inhibition?
Davies NM
Clin Pharmacokinet; 1997 Dec; 33(6):404-16. PubMed ID: 9435990
[TBL] [Abstract][Full Text] [Related]
52. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation.
Futaki N; Arai I; Hamasaka Y; Takahashi S; Higuchi S; Otomo S
J Pharm Pharmacol; 1993 Aug; 45(8):753-5. PubMed ID: 8229647
[TBL] [Abstract][Full Text] [Related]
53. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
54. Investigations of indomethacin-induced gastric ulcer in rats.
Kapui Z; Boér K; Rózsa I; Blaskó G; Hermecz I
Arzneimittelforschung; 1993 Jul; 43(7):767-71. PubMed ID: 8369011
[TBL] [Abstract][Full Text] [Related]
55. Two distinct effects of 12S-hydroxyeicosatetraenoic acid on platelet aggregation by zooxanthellatoxin-A and ionomycin.
Rho MC; Nakahata N; Ohizumi Y
Jpn J Pharmacol; 1998 Jan; 76(1):117-20. PubMed ID: 9517414
[TBL] [Abstract][Full Text] [Related]
56. Effects of nabumetone and dipyrone on experimentally induced gastric ulcers in rats.
Yıldırım E; Sağıroğlu O; Kılıç FS; Erol K
Inflammation; 2013 Apr; 36(2):476-81. PubMed ID: 23129452
[TBL] [Abstract][Full Text] [Related]
57. Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone.
Hilleman DE; Mohiuddin SM; Lucas BD
Am J Med; 1993 Aug; 95(2A):30S-34S. PubMed ID: 8357000
[TBL] [Abstract][Full Text] [Related]
58. The effect of tramadol and indomethacin coadministration on gastric barrier function in dogs.
Hill TL; Lascelles BD; Law JM; Blikslager AT
J Vet Intern Med; 2014; 28(3):793-8. PubMed ID: 24684670
[TBL] [Abstract][Full Text] [Related]
59. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
[TBL] [Abstract][Full Text] [Related]
60. Endoscopic studies of nabumetone in patients with rheumatoid arthritis. A comparative endoscopic and histologic evaluation.
Greb WH; von Schrader HW; Cerlek S; Dominis M; Hauptmann E; Zenić N
Am J Med; 1987 Oct; 83(4B):19-24. PubMed ID: 3318423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
